Norhammar A, Tenerz A, Nilsson G, et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet. 2002;359(9324):2140–4.
Article
CAS
Google Scholar
Bartnik M, Rydén L, Ferrari R, et al. The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe The Euro Heart Survey on diabetes and the heart. Eur Heart J. 2004;25(21):1880–90.
Article
CAS
Google Scholar
Hu DY, Pan CY, Yu JM. The relationship between coronary artery disease and abnormal glucose regulation in China: the China Heart Survey. Eur Heart J. 2006;27(21):2573–9.
Article
CAS
Google Scholar
Tamita K, Katayama M, Takagi T, et al. Impact of newly diagnosed abnormal glucose tolerance on long-term prognosis in patients with acute myocardial infarction. Circ J. 2007;71(6):834–41.
Article
Google Scholar
Bartnik M, Malmberg K, Norhammar A, et al. Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction. Eur Heart J. 2004;25:1990–7.
Article
CAS
Google Scholar
Matz K, Keresztes K, Tatschl C, et al. Disorders of glucose metabolism in acute stroke patients: an underrecognized problem. Diabetes Care. 2006;29(4):792–7.
Article
CAS
Google Scholar
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33(Suppl 1):S62-69.
Article
Google Scholar
Consultation WHO. Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. Abbreviated report of a WHO consultation. Geneva: World Health Organization; 2011.
Google Scholar
Matz K, Teuschl Y, Firlinger B, et al. ASPIS Study Group. Multidomain lifestyle interventions for the prevention of cognitive cecline after ischemic stroke: a randomized trial. Stroke. 2015;46:2874–80.
Article
Google Scholar
World Health Organization. Definition, diagnosis and Classification of diabetes mellitus and its complications: report of a WHO consultation. Part 1: diagnosis and classification of diabetes mellitus. Geneva: World Health Organization; 1999.
Google Scholar
Jia Q, Zheng H, Zhao X, et al. Investigators for the Survey on Abnormal Glucose Regulation in Patients With Acute Stroke Across China (ACROSS-China). Abnormal glucose regulation in patients with acute stroke across China: prevalence and baseline patient characteristics. Stroke. 2012;43:650–7.
Article
CAS
Google Scholar
Vancheri F, Curcio M, Burgio A, et al. Impaired glucose metabolism in patients with acute stroke and no previous diagnosis of diabetes mellitus. QJM. 2005;98(12):871–8.
Article
CAS
Google Scholar
Wu S, Shi Y, Pan Y, Li J, et al. Glycated hemoglobin independently or in combination with fasting plasma glucose versus oral glucose tolerance test to detect abnormal glycometabolism in acute ischemic stroke: a Chinese cross-sectional study. BMC Neurol. 2014;12(14):177.
Article
Google Scholar
Zhang X, Shi Q, Zheng H, et al. Prevalence of abnormal glucose regulation according to different diagnostic driteria in ischaemic Ssroke without a history of diabetes. Biomed Res Int. 2018. https://doi.org/10.1155/2018/8358724.
Article
PubMed
PubMed Central
Google Scholar
Tuomilehto J, Lindström J, Eriksson JG, Finnish Diabetes Prevention Study Group, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344(18):1343–50.
Article
CAS
Google Scholar
Knowler WC, Barrett-Connor E, Fowler SE, Diabetes Prevention Program Research Group, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393–403.
Article
CAS
Google Scholar
Chiasson JL, Josse RG, Gomis R, STOP-NIDDM Trial Research Group, et al. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet. 2002;359(9323):2072–7.
Article
CAS
Google Scholar
Kernan WN, Viscoli CM, Furie KL, IRIS Trial Investigators, et al. Pioglitazone after ischemic stroke or transient ischemic attack. N Engl J Med. 2016;374(14):1321–31.
Article
CAS
Google Scholar
le Roux CW, Astrup A, Fujioka K, SCALE Obesity Prediabetes NN8022-1839 Study Group, et al. 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial. Lancet. 2017;389(10077):1399–409.
Article
Google Scholar
Lee M, Saver JL, Liao HW, Lin CH, et al. Pioglitazone for secondary stroke prevention: a systematic review and meta-analysis. Stroke. 2017;48:388–93.
Article
CAS
Google Scholar
Shahim B, Gyberg V, De Bacquer D, et al. Undetected dysglycaemia common in primary care patients treated for hypertension and/or dyslipidaemia: on the need for a screening strategy in clinical practice. A report from EUROASPIRE IV a registry from the EuroObservational Research Programme of the European Society of Cardiology. Cardiovasc Diabetol. 2018;24(17):21.
Article
Google Scholar
Dorr R, Stumpf J, Spitzer SG, et al. Prevalence of undetected diabetes mellitus in invasive and interventional cardiology Silent diabetes in the catheterization laboratory. Herz. 2012;37(3):244–50.
Article
CAS
Google Scholar
Qiao Q, Pyorala K, Pyorala M, et al. Two-hour glucose is a better risk predictor for incident coronary heart disease and cardiovascular mortality than fasting glucose. Eur Heart J. 2002;23(16):1267–75.
Article
CAS
Google Scholar
DECODE Study Group, the European Diabetes Epidemiology Group. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Archiv Internal Med. 2001;1613:397–405.
Google Scholar
Temelkova-Kurktschiev TS, Koehler C, et al. Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level. Diabetes Care. 2000;23(12):1830–4.
Article
CAS
Google Scholar
Foreman YD, Brouwers MCGJ, et al. The oral glucose tolerance test-derived incremental glucose peak is associated with greater arterial stiffness and maladaptive arterial remodeling: The Maastricht Study. Cardiovasc Diabetol. 2019;14(18):152.
Article
Google Scholar
DECODE Study Group, European Diabetes Epidemiology Group. Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases? Diabetes care. 2003;26(3):688–96.
Article
Google Scholar
Qiao Q, Dekker JM, de Vegt F, et al. Two prospective studies found that elevated 2-hr glucose predicted male mortality independent of fasting glucose and HbA1c. J Clin Epidemiol. 2004;57(6):590–6.
Article
Google Scholar
Meigs JB, Nathan DM, D’Agostino RB, et al. Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study. Diabetes Care. 2002;25:1845–50.
Article
Google Scholar
Shahim B, De Bacquer D, De Backer G, et al. The prognostic value of fasting plasma glucose, two-hour postload glucose, and HbA1c in patients with coronary artery disease: a report from EUROASPIRE IV: a survey from the European Society of Cardiology. Diabetes Care. 2017;40(9):1233–40.
Article
CAS
Google Scholar
Jing J, Pan Y, Zhao X, et al. Prognosis of ischemic stroke with newly diagnosed diabetes mellitus according to hemoglobin A1c criteria in Chinese population. Stroke. 2016;47:2038–44.
Article
CAS
Google Scholar
Capes SE, Hunt D, Malmberg K, et al. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke. 2001;32:2426–32.
Article
CAS
Google Scholar
Osei E, den Hertog HM, Fonville S, et al. Prediction of persistent impaired glucose tolerance in patients with minor ischemic stroke or transient ischemic attack. J Stroke Cerebrovasc Dis. 2020;29(6):104815.
Article
Google Scholar